馃嚦馃嚤 Pharming Group NV
PHARM.ASFundamentals
Gross Margin
87.9%
Op. Margin
5.6%
Net Margin
0.8%
ROIC
4.7%
Rev Growth
26.6%
Valuation
Price
0.98 EUR
Day
+1.03%
52-Week Range
0.83 - 1.82
Market Cap
695M EUR
Fwd P/E
30.9x
EV/EBITDA
19.5x
Div Yield
-
Annual income statement #
Pharming Group NV annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 376.1m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 376.1m | 20.9m | 3.0m | 0.8% |
| 2024 | 297.1m | -3.7m | -11.8m | -4.0% |
| 2023 | 226.9m | -20.4m | -9.8m | -4.3% |
| 2022 | 205.6m | 18.2m | 13.7m | 6.7% |
| 2021 | 189.9m | 27.8m | 16.0m | 8.4% |
| 2020 | 228.4m | 82.1m | 37.7m | 16.5% |
| 2019 | 189.3m | 68.2m | 40.5m | 21.4% |
| 2018 | 154.6m | 43.5m | 28.6m | 18.5% |
| 2017 | 107.5m | 26.3m | -95.9m | -89.2% |
| 2016 | 16.7m | -12.1m | -18.4m |
Financial Data #
Segment Breakdown #
Peers #
GNFT.PA DBV.PA GUBRA.CO MEDCL.PA VLA.PA IVA.PA VITR.ST HNSA.ST ALVIO.PA PHM.MC 路
Compare in Screener
Dividends
Bubble
Short Interest #
Current: 0.60% 路
30d ago: 12.01% 路
All-time high: 13.92% (2024-02-02)
Two Sigma Investments, LP 1.28%
路 Citadel Advisors LLC 1.00%
路 Walleye Capital LLC 0.95%
路 Capstone Volatility Master (Cayman) Limited 0.80%
路 D. E. Shaw & Co., L.P. 0.69%
路 Lazard Asset Management LLC 0.60%
路 Citadel Advisors LLC 0.60%
路 Whitebox Advisors LLC 0.58%
路 Spark Investment Management LLC 0.52%
Events #
| Date | Type | Details | Price | Amount |
|---|